help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Machens, A.
Right arrow Articles by Dralle, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Machens, A.
Right arrow Articles by Dralle, H.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 3 1104-1109
Copyright © 2001 by The Endocrine Society


Original Studies

Genotype-Phenotype Correlations in Hereditary Medullary Thyroid Carcinoma: Oncological Features and Biochemical Properties1

Andreas Machens, Oliver Gimm, Raoul Hinze, Wolfgang Höppner, Bernhard O. Boehm and Henning Dralle

Departments of General Surgery (A.M., O.G., H.D.) and Pathology (R.H.), Martin Luther University Halle-Wittenberg, D-06097 Halle/Saale; Institute for Hormone and Fertility Research, University of Hamburg, Molecular Diagnostic Group (W.H.), D-22529 Hamburg; and Division of Endocrinology, Department of Internal Medicine I, University of Ulm (B.O.B.), D-89081 Ulm, Germany

Address all correspondence and requests for reprints to: Andreas Machens, M.D., Department of General Surgery, Martin Luther University Halle-Wittenberg, Ernst Grube Strasse 40, D-06097 Halle/Saale, Germany.

In hereditary medullary thyroid carcinoma (MTC), few genotype-phenotype correlations have been established. RET genotypes (exons 10, 11, 13, and 14) of 63 patients with hereditary MTC (from November 1994 to October 1999) were correlated with age at diagnosis, sex, the TNM system, and basal calcitonin levels. Mutations in exons 10, 11, 13, and 14 were demonstrated in 22% (14 of 63), 54% (34 of 63), 21% (13 of 63), and 3% (2 of 63). The median ages at diagnosis differed significantly (38, 27, 52, and 62 yr; P = 0.003). When grouped by cysteine codons (exons 10 and 11 vs. exons 13 and 14), this difference became even more evident (30 vs. 56 yr; P = 0.001). Apart from age at diagnosis, no other significant associations were noted. Based hereon, three MTC risk groups were devised according to genotype: a high risk group (codons 634 and 618) with the youngest ages of 3 and 7 yr at diagnosis; an intermediate risk group (codons 790, 620, and 611) with ages of 12, 34, and 42 yr; and a low risk group (codons 768 and 804) with ages of 47 and 60 yr, respectively. Age at diagnosis was unrelated to specific nucleotide and amino acid exchange within each codon.

The current data demonstrate that there is a significant genotype-phenotype correlation, allowing for a more individualized approach to the timing and extent of prophylactic surgery.




This article has been cited by other articles:


Home page
Cancer Res.Home page
W. van Veelen, C. J.R. van Gasteren, D. S. Acton, D. S. Franklin, R. Berger, C. J.M. Lips, and J. W.M. Hoppener
Synergistic Effect of Oncogenic RET and Loss of p18 on Medullary Thyroid Carcinoma Development
Cancer Res., March 1, 2008; 68(5): 1329 - 1337.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
V. Johanson, H. Ahlman, P. Bernhardt, S. Jansson, L. Kolby, F. Persson, G. Stenman, C. Sward, B. Wangberg, M. Stridsberg, et al.
A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis
Endocr. Relat. Cancer, June 1, 2007; 14(2): 433 - 444.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
E. Korpershoek, B.-J. Petri, F. H van Nederveen, W. N M Dinjens, A. A Verhofstad, W. W de Herder, S. Schmid, A. Perren, P. Komminoth, and R. R de Krijger
Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma
Endocr. Relat. Cancer, June 1, 2007; 14(2): 453 - 462.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
K Frank-Raue, H Buhr, H Dralle, E Klar, N Senninger, T Weber, S Rondot, W Hoppner, and F Raue
Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype.
Eur. J. Endocrinol., August 1, 2006; 155(2): 229 - 236.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Frank-Raue, S. Rondot, W. Hoeppner, P. Goretzki, F. Raue, and W. Meng
Coincidence of Multiple Endocrine Neoplasia Types 1 and 2: Mutations in the RET Protooncogene and MEN1 Tumor Suppressor Gene in a Family Presenting with Recurrent Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4063 - 4067.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S Jindrichova, J Vcelak, P Vlcek, M Neradilova, J Nemec, and B Bendlova
Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic
J. Endocrinol., November 1, 2004; 183(2): 257 - 265.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. Arighi, A. Popsueva, D. Degl'Innocenti, M. G. Borrello, C. Carniti, N. M. Perala, M. A. Pierotti, and H. Sariola
Biological Effects of the Dual Phenotypic Janus Mutation of ret Cosegregating with Both Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease
Mol. Endocrinol., April 1, 2004; 18(4): 1004 - 1017.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Machens, P. Niccoli-Sire, J. Hoegel, K. Frank-Raue, T. J. van Vroonhoven, H.-D. Roeher, R. A. Wahl, P. Lamesch, F. Raue, B. Conte-Devolx, et al.
Early Malignant Progression of Hereditary Medullary Thyroid Cancer
N. Engl. J. Med., October 16, 2003; 349(16): 1517 - 1525.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. K. Punales, H. Graf, J. L. Gross, and A. L. Maia
RET Codon 634 Mutations in Multiple Endocrine Neoplasia Type 2: Variable Clinical Features and Clinical Outcome
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2644 - 2649.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
G. Szinnai, C. Meier, P. Komminoth, and U. W. Zumsteg
Review of Multiple Endocrine Neoplasia Type 2A in Children: Therapeutic Results of Early Thyroidectomy and Prognostic Value of Codon Analysis
Pediatrics, February 1, 2003; 111(2): e132 - 139.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. H. Menko, R. B. van der Luijt, I. A. J. de Valk, A. W. F. T. Toorians, J. M. Sepers, P. J. van Diest, and C. J. M. Lips
Atypical MEN Type 2B Associated with Two Germline RET Mutations on the Same Allele Not Involving Codon 918
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 393 - 397.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society